Drug Shortage Report for APO-SALBUTAMOL HFA

Last updated on 2020-09-14 History
Report ID 108970
Drug Identification Number 02245669
Brand name APO-SALBUTAMOL HFA
Common or Proper name SALBUTAMOL INHALER
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 100MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration INHALATION
Packaging size 200MD
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-18
Estimated end date 2020-09-18
Actual end date 2020-09-11
Shortage status Resolved
Updated date 2020-09-14
Company comments Limited inventory will be available starting mid June 2020
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2020-09-14 French Compare
v16 2020-09-14 English Compare
v15 2020-09-09 French Compare
v14 2020-09-09 English Compare
v13 2020-09-01 French Compare
v12 2020-09-01 English Compare
v11 2020-05-12 French Compare
v10 2020-05-12 English Compare
v9 2020-05-05 French Compare
v8 2020-05-05 English Compare
v7 2020-05-05 French Compare
v6 2020-05-05 English Compare
v5 2020-04-20 French Compare
v4 2020-04-20 English Compare
v3 2020-03-19 English Compare
v2 2020-03-18 French Compare
v1 2020-03-18 English Compare

Showing 1 to 17 of 17